The applications of nanotechnology in prevention of chemotherapy-induced hearing impairment
Applications open: 1/11/2021
Applications close: 1/06/2022
About this scholarship
This scholarship is part of the newly established alliance between Curtin University and Ear Science Institute Australia (Ear Science). The aim is to support and grow the ongoing collaboration between Curtin and Ear Science and engage best students to grow their skills and capabilities and benefit everyone involved. The proposed research is at the forefront of cutting-medical nanotechnologies in the context of hearing loss, focusing on improving the lives of children with cancer, with the ultimate goal is to prevent these children from loosing their hearing and suffer short-and long-term consequences, including social isolation, poor academic performance and mental illness.
- Future Students
- Faculty of Health Sciences
- Higher Degree by Research
- Australian Citizen
- Australian Permanent Resident
- New Zealand Citizen
- Permanent Humanitarian Visa
- International Student
- Merit Based
This scholarship provides a living stipend of $28,597 p.a. pro rata indexed, based on full-time studies, for up to a maximum of 3 years.
Any HDR student wishing to study pharmaceutical sciences and hearing loss treatment.
The eligibility is consistent with Curtin eligibility criteria and include:
· Domestic and international
· Full-time enrolment
· Successful recipients must also not be in receipt of any other scholarship
To apply for this project opportunity, please submit an email to the Project Lead listed below. The email must include your current curriculum vitae, a summary of your research skills and experience and the reason you are interested in this specific project.
Project Lead: Associate Professor Hani Al-Salami
Eligible to enrol in a Higher Degree by Research course at Curtin University
A/Prof Hani Al-Salami (Head of Hearing Therapeutics Department)